Stop TB Partnership

Daniel Chin Receives Top Award from China for Contribution to TB Control

24 February 2015 - The Gates Foundation is delighted to announce that Daniel Chin, Senior Program Officer, TB, has been awarded the prestigious "Chinese Medical Science and Technology Award." This annual award, established in 2001 by the National Health and Family Planning Commission (formerly the Ministry of Health) and the Ministry of Science and Technology, is a top national award presented to individuals and organizations that have made considerable contributions to innovation in medical science and technology in China. Recipients are selected by national expert committees brought together by the Chinese Medical Association.

Daniel has been working on TB in China for over 20 years and has been with the foundation's China office since its inception in 2007. The award recognizes his considerable contribution to the fight against TB over the last decade, notably in guiding the nationwide expansion of the DOTS (directly observed therapy, short course) strategy, which achieved a remarkable 65 percent reduction in the prevalence of smear-positive TB across the country.

Daniel has partnered with the Chinese government on the development of a comprehensive and innovative program to modernize TB control in China including the universal access to treatment for multidrug-resistant forms of TB (MDRTB). In a population of 18 million people, the program succeeded in identifying nine times more MDRTB cases than the existing system, reduced the time needed for diagnosis and treatment initiation by 90 percent, reduced premature treatment discontinuation (a major cause of further drug resistance) by 90 percent, and reduced patient expenses to only 10 percent of the treatment charges.

Following this remarkable success, the National Health and Family Planning Commission has already started scaling-up various aspects of the program across China and the program results are being incorporated in the next 5-year national TB control plan (2016-20) and then scale-up nationwide.